These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 34837636)

  • 1. Epidemiology, Demographics, Triptan Contraindications, and Prescription Patterns of Patients with Migraine: A German Claims Database Study.
    Gendolla A; Rauer N; Kraemer S; Schwerdtner I; Straube A
    Neurol Ther; 2022 Mar; 11(1):167-183. PubMed ID: 34837636
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identifying the factors underlying discontinuation of triptans.
    Wells RE; Markowitz SY; Baron EP; Hentz JG; Kalidas K; Mathew PG; Halker R; Dodick DW; Schwedt TJ
    Headache; 2014 Feb; 54(2):278-89. PubMed ID: 24001117
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Health care resource utilization following initiation of a triptan: a retrospective claims analysis.
    Messali A; Owens G; Bloudek L; Kori S; Cole A; Chia J
    J Manag Care Spec Pharm; 2014 Apr; 20(4):368-75. PubMed ID: 24684641
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Administrative prevalence and incidence, characteristics and prescription patterns of patients with migraine in Germany: a retrospective claims data analysis.
    Roessler T; Zschocke J; Roehrig A; Friedrichs M; Friedel H; Katsarava Z
    J Headache Pain; 2020 Jul; 21(1):85. PubMed ID: 32631274
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Triptan medication use among patients with migraine with contraindications in the US.
    Pero A; Pace A; Dhamoon MS
    Headache; 2022 Jul; 62(7):883-889. PubMed ID: 35670141
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Triptans and vascular comorbidity in persons over fifty: Findings from a nationwide insurance database - A cohort study.
    Zebenholzer K; Gall W; Gleiss A; Pavelic AR; Wöber C
    Headache; 2022 May; 62(5):604-612. PubMed ID: 35593784
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coprescription of triptans with potentially interacting medications: a cohort study involving 240,268 patients.
    Tepper S; Allen C; Sanders D; Greene A; Boccuzzi S
    Headache; 2003 Jan; 43(1):44-8. PubMed ID: 12864757
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Triptan persistency among newly initiated users in a pharmacy claims database.
    Katić BJ; Rajagopalan S; Ho TW; Chen YT; Hu XH
    Cephalalgia; 2011 Mar; 31(4):488-500. PubMed ID: 20937605
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Geographic variation in the use of triptans and opioids for the acute treatment of migraine attacks.
    Lee JH; Shewale AR; Barthold D; Devine B
    Headache; 2021 Nov; 61(10):1499-1510. PubMed ID: 34841520
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Patterns of prescription and usage of triptans in Alsace (France): misuse is frequent and avoidable].
    Perearnau P; Vuillemet F; Schick J; Weill G
    Rev Neurol (Paris); 2006 Mar; 162(3):347-57. PubMed ID: 16585890
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rates and reasons for discontinuation of triptans and opioids in episodic migraine: results from the American Migraine Prevalence and Prevention (AMPP) study.
    Holland S; Fanning KM; Serrano D; Buse DC; Reed ML; Lipton RB
    J Neurol Sci; 2013 Mar; 326(1-2):10-7. PubMed ID: 23394974
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Perinatal use of triptans and other drugs for migraine-A nationwide drug utilization study.
    Tauqeer F; Wood M; Hjorth S; Lupattelli A; Nordeng H
    PLoS One; 2021; 16(8):e0256214. PubMed ID: 34424941
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Utilisation of prescription and over-the-counter triptans: a cross-sectional study in Stockholm, Sweden.
    Frisk P; Sporrong SK; Ljunggren G; Wettermark B; von Euler M
    Eur J Clin Pharmacol; 2016 Jun; 72(6):747-54. PubMed ID: 26922586
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Results of a 2-year retrospective cohort study of newly prescribed triptan users in European nationwide practice databases.
    Ng-Mak DS; Chen YT; Ho TW; Stanford B; Roset M
    Cephalalgia; 2012 Sep; 32(12):875-87. PubMed ID: 22833612
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Usage of triptans among migraine patients: an audit in nine GP practices.
    Williams D; Cahill T; Dowson A; Fearon H; Lipscombe S; O'Sullivan E; Rees T; Strang C; Valori A; Watson D
    Curr Med Res Opin; 2002; 18(1):1-9. PubMed ID: 11999139
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Triptan education and improving knowledge for optimal migraine treatment: an observational study.
    Baron EP; Markowitz SY; Lettich A; Hastriter E; Lovell B; Kalidas K; Dodick DW; Schwedt TJ;
    Headache; 2014 Apr; 54(4):686-97. PubMed ID: 24520930
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of healthcare resource utilization and costs among patients with migraine with potentially adequate and insufficient triptan response.
    Marcus SC; Shewale AR; Silberstein SD; Lipton RB; Young WB; Viswanathan HN; Doshi JA
    Cephalalgia; 2020 Jun; 40(7):639-649. PubMed ID: 32223301
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    Martínez-Pías E; García-Azorín D; Minguez-Olaondo A; Trigo J; Sierra Á; Ruiz M; Guerrero ÁL
    Expert Rev Neurother; 2021 Jan; 21(1):123-130. PubMed ID: 33111580
    [No Abstract]   [Full Text] [Related]  

  • 19. Acute migraine treatment with oral triptans and NSAIDs in a managed care population.
    Ng-Mak DS; Hu XH; Chen YT; Ma L
    Headache; 2008 Sep; 48(8):1176-85. PubMed ID: 18819177
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Triptans for Acute Migraine Headache: Current Experience With Triptan Use and Prescription Habits in a Tertiary Care Headache Outpatient Clinic: An Observational Study.
    Fischer M; Frank F; Wille G; Klien S; Lackner P; Broessner G
    Headache; 2016 Jun; 56(6):952-60. PubMed ID: 27091593
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.